Carmen Espinet Mestre

Roy R; Lorca C; Mulet M; Sánchez Milán JA; Baratas A; de la Casa M; Espinet C; Serra A; Gallart-Palau X

Altered ureido protein modification profiles in seminal plasma extracellular vesicles of non-normozoospermic men.

Frontiers in Endocrinology 14 1113824-1113824. 22/03/2023.

[doi:10.3389/fendo.2023.1113824]

Altes, G; Vaquero, M; Cuesta, S; Anerillas, C; Macia, A; Espinet, C; Ribera, J; Bellusci, S; Klein, OD; Yeramian, A; Dolcet, X; Egea, J; Encinas, M

A dominant negative mutation uncovers cooperative control of caudal Wolffian duct development by Sprouty genes

Cellular And Molecular Life Sciences 79 514-514. 01/10/2022.

[doi:10.1007/s00018-022-04546-1]

Olabiyi, BF; Fleitas, C; Zammou, B; Ferrer, I; Rampon, C; Egea, J; Espinet, C

proNGF Involvement in the Adult Neurogenesis Dysfunction in Alzheimer's Disease

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 22 -. 04/10/2021.

[doi:10.3390/ijms221910744]

Fleitas C; Marfull-Oromí P; Chauhan D; Del Toro D; Peguera B; Zammou B; Rocandio D; Klein R; Espinet C; Egea J

FLRT2 and FLRT3 cooperate in maintaining the tangential migratory streams of cortical interneurons during development.

JOURNAL OF NEUROSCIENCE 41 7350-7362. 23/07/2021.

[doi:10.1523/JNEUROSCI.0380-20.2021]

Marfull-Oromí P; Fleitas C; Zammou B; Rocandio D; Ballester-Lurbe B; Terrado J; Perez-Roger I; Espinet C; Egea J

Genetic ablation of the Rho GTPase Rnd3 triggers developmental defects in internal capsule and the globus pallidus formation.

JOURNAL OF NEUROCHEMISTRY 158 197-216. 01/07/2021.

[doi:10.1111/jnc.15322]

Fleitas, C; Piñol-Ripoll G; Marfull, P; Rocandio, D; Ferrer, I; Rampon, C; Egea, J; Espinet, C

proBDNF is modified by advanced glycation end products in Alzheimer's disease and causes neuronal apoptosis by inducing p75 neurotrophin receptor processing

MOLECULAR BRAIN 11 68-68. 14/11/2018.

[doi:10.1186/s13041-018-0411-6]

Espinet, C.; Pinol, G.; Fleitas, C.; Arias, A.; Blasco, E.

Imbalance in BDNF and probdnf levels in serum and cerebroespinal fluid in untreated Alzheimer's disease patients

JOURNAL OF NEUROCHEMISTRY 142 156-156. 01/08/2017.

Espinet C; Gonzalo H; Fleitas C; Menal MJ; Egea J

Oxidative Stress and Neurodegenerative Diseases: A Neurotrophic Approach

CURRENT DRUG TARGETS 16 20-30. 01/01/2015.

[doi:10.2174/1389450116666150107153233]

Real, Sebastian; Espada, Lilia; Espinet, Carme; Santidrian, Antonio F.; Tauler, Albert

Study of the in vivo phosphorylation of E2F1 on Ser403

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH 1803 912-918. 01/08/2010.

[doi:10.1016/j.bbamcr.2010.04.003]

Kichev, Anton; Ilieva, Ekaterina V.; Pinol-Ripoll, Gerard; Podlesniy, Petar; Ferrer, Isidro; Portero-Otin, Manuel; Pamplona, Reinald; Espinet, Carme

Cell death and learning impairment in mice caused by in vitro modified pro-NGF can be related to its increased oxidative modifications in Alzheimer disease.

AMERICAN JOURNAL OF PATHOLOGY 175 2574-2585. 01/12/2009.

[doi:10.2353/ajpath.2009.090018]

Espada, Lilia; Udapudi, Basavaraj; Podlesniy, Petar; Fabregat, Isabel; Espinet, Carme; Tauler, Albert

Apoptotic action of E2F1 requires glycogen synthase kinase 3-beta activity in PC12 cells

JOURNAL OF NEUROCHEMISTRY 102 2020-2028. 01/09/2007.

[doi:10.1111/j.1471-4159.2007.04686.x]

Podlesniy, P; Kichev, A; Pedraza, C; Saurat, J; Encinas, M; Perez, B; Ferrer, I; Espinet, C

Pro-NGF from Alzheimer's disease and normal human brain displays distinctive abilities to induce processing and nuclear translocation of intracellular domain of p75NTR and apoptosis.

AMERICAN JOURNAL OF PATHOLOGY 169 119-131. 01/07/2006.

[doi:10.2353/ajpath.2006.050787]